Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,245 across all filing types
Latest filing 2021-09-18 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is extremely short (303 characters) and consists only of addresses and stock exchange listing department references without any substantive content, financial data, or report details. It does not contain any report, announcement of voting results, management changes, or financial information. Given the lack of content and the nature of the text, it fits best as a Regulatory Filing (RNS) which is a fallback category for miscellaneous filings that do not fit other categories.
2021-09-18 English
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform you that, the Company has purchased Immovable ....
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the purchase of immovable property by the company. It is a regulatory announcement about a material event (purchase of property) and includes a trading window closure notice under insider trading regulations. The document is short (2470 characters) and does not contain financial statements or detailed financial data. It is not a report but a regulatory disclosure of a corporate event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-09-18 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document contains multiple public notices related to property transactions, loan defaults, sale notices under the Securitization and Reconstruction of Financial Assets and Enforcement of Security Interest Act, 2002, and show cause notices regarding wilful defaulters. It includes detailed legal and financial information about loan accounts, default status, and sale of mortgaged properties. There is no indication that this is a full annual or interim financial report, earnings release, or management discussion. The document is not a report publication announcement or a certification. It is primarily a regulatory announcement related to legal and financial enforcement actions by banks and financial institutions. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-09-16 English
In continuation to our intimated details dated September 15, 2021 and Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we submit ....
Regulatory Filings Classification · 95% confidence The document contains multiple public notices related to financial and legal matters such as corrigendum to AGM notice, sale notices for gold loans, show cause notices for wilful defaulters, and possession notices under the SARFAESI Act. It includes regulatory announcements and legal notifications but does not contain any financial statements, management discussion, or detailed financial data. The document is a collection of regulatory and legal announcements rather than a formal financial report or meeting material. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements and compliance documents.
2021-09-16 English
Corrigendum
AGM Information Classification · 95% confidence The document is a detailed notice and corrigendum related to the 36th Annual General Meeting (AGM) of Bliss GVS Pharma Ltd. It includes agenda items such as adoption of financial statements, declaration of dividends, and multiple appointments and re-appointments of directors and whole-time directors. The document references the Annual Report for FY 2020-21 but is itself a notice for the AGM, including resolutions to be passed at the meeting. It is not the Annual Report itself, nor a transcript or earnings release. The presence of detailed resolutions and director appointments aligns with typical AGM notices. Therefore, the document is best classified as AGM Information (AGM-R). The document length (15,000 characters) and content confirm it is the meeting notice and related corrigendum, not just an announcement or a brief summary.
2021-09-15 English
Please find the attachment.
AGM Information Classification · 95% confidence The document is a detailed notice and corrigendum related to the 36th Annual General Meeting (AGM) of Bliss GVS Pharma Ltd. It includes agenda items such as adoption of financial statements, declaration of dividends, re-appointments and appointments of directors, and special resolutions. The document references the Annual Report for FY 2020-21 but is itself a notice for the AGM, including explanatory statements and resolutions to be passed at the meeting. It is not the Annual Report itself, nor a transcript or earnings release. The presence of detailed resolutions and meeting agenda confirms it is AGM-related material. Therefore, the document fits the category of AGM Information (AGM-R). The document length and content confirm it is not a brief announcement or corrigendum only, but the full AGM notice with detailed business to be transacted.
2021-09-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.